References to Primary Literature
- LANE DP, CRAWFORD LV: T antigen is bound to a hostprotein in SV40 transformed cells. Nature (1979) 278:261–263.
- FINLAY CA, HINDS PW, LEVINE AJ: The p53 protoonco-gene can act as a suppressor of transformation. Cell (1989) 57:1083–1093.
- MILLER C, MOHANDAS T, WOLF D etal.: The human p53 gene is localised to short arm of chromosome 17. Nature (1986) 319:783–784.
- KERN SE, KINZLER KW, BRUSKIN A et al: Identification of p53 as a sequence specific DNA binding protein. Science (1991) 252: 1708-1711.
- FAKHARZADEH SS, TRUSKO SP, GEORGE DL: Tn-mourigenic potential associated with enhanced expres-sion of a gene that is amplified in a mouse tumour cell line. EMBO J. (1991) 10:1565–1569.
- OLINER JD, KINZLER KW, MELTZER PS, GEORGE DL, VOGEISTEIN B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (1993) 358:80–83.
- MOMAND J, ZAMBE1 1 I, GP, OLSON DC, LEVINE AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 69:1237–1245.
- °LINER JD, P1ETENPOL JA, THIAGALINGAM S etal.: Onco-protein MDM-2 conceals the activation domain of tu-mour suppressor p53. Nature (1993) 362:857–860.
- BARAK Y, YUVEN T, HAFFNE R, OREN M:Mdm-2 expres-sion is induced by wild type p53 activity. EMBOJ (1993) 12:461–468.
- WU X, BAYLE JH, OLSO D, LEVINE AJ: The p53-MDM-2autoregulatory feedback loop. Genes Development (1993) 7:1126–1132.
- CHEN J, MARECHAL V, LEVINE AI: Mapping of the p53and mdm-2 interaction domains. Mol. Cell Biol. (1993) 13:4107–4114.
- BODDY MN, FREEMONT PS, BORDEN KLB: The p53-asso-dated protein MDM-2 contains a newly characterized zinc-finger domain called the RING finger. 77BS (1994) 19:188–189.
- XIAO Z-X, CHEN J, LEVINE AJ et al.: Interaction between the retinoblastoma protein and the oncoprotein MOM-2. Nature (1995) 375:694–698.
- MARTIN K, TROUCHE D, HAGEMEIER C et at: Stimulationof E2F1/DP1 transcriptional activity by MDM-2 onco-protein. Nature (1995) 375:691–694.
- DUBS-POTERSZMAN M-C, TOCQUE B, WASYLYK B: MOM-2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest. Oncogene (1995) 11:2445–2449
- SIGALAS I, CALVERT All, ANDERSON JJ, NEAL DE, LUNECJ: Alternatively spliced MDM-2 transcripts with loss of p53 binding domain sequences: Transforming ability and frequent detection in human cancer. Nature Medi-cine(1996) 8:1–6.
- LUNA RMD, WAGNER DS, LOZANO G: Rescue of earlyembryonic lethality in MDM-2-deflcient mice by dele-tion of p53. Nature (1995) 378:203–206.
- JONES SN, ROE AE, DONEHOWER LA, BRADLEY A: Rescueof embryonic letbAlity in MDM-2-deficient mice by absence of p53. Nature (1995) 378:206–208.